Updates

Equals Group

February 2024

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Equals’ preclose statement was overshadowed by a Strategic review initiated by management, which includes seeking a possible trade buyer. The takeover panel has given PE firm Madison Dearborn Partners until 21 February to make an offer. Sales for the year to end December were up 37% to £95.5m driven mostly by the Solutions side with continued growth in adjusted EBITDA. Net cash has climbed to £18.3m with a further £2.3m cash-in-transit arriving just after the period end. Revenue per working day was £380.5k, up 36% year-on-year. Equals will report its results in the week of 15 April 2024. Await developments. ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Card Factory - Trading at top end of forecast range

Nexteq

Equals (October 2023)

Equals (August 2023)

Equals - Scope for material outperformance (June 2023)

Equals - Forecasts upgraded by 16% (April 2023)

Equals (May 2021)

Equals Group - Sales pivot to B2B - now 66% sales (November 2020)

Equals Group (March 2020)

Equals Group (November 2019)

Equals Group - Placing and open offer to raise Â£16m (September 2019)

Equals Group - New name for FairFX (July 2019)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X